Ananda Pharma (STU:1FX) Ending Cash Position: €0.00 Mil (As of Jul. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ananda Pharma Ending Cash Position?

Ananda Pharma STU:1FX Ending Cash Position is €0.00 Mil as of Jul. 2025. The stock has 5 warning signs investors should review.

Ananda Pharma's Ending Cash Position for the quarter that ended in Jul. 2025 was €0.00 Mil.

Ananda Pharma's annual Ending Cash Position increased from Jan. 2023 (€0.02 Mil) to Jan. 2024 (€0.10 Mil) and increased from Jan. 2024 (€0.10 Mil) to Jan. 2025 (€1.99 Mil).

Ananda Pharma Ending Cash Position Related Terms

Ananda Pharma Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Ananda Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Ending Cash Position Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Ending Cash Position
Get a 7-Day Free Trial 0.00 0.00 0.02 0.10 1.99

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ananda Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Ananda Pharma's Ending Cash Position for the fiscal year that ended in Jan. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.1+1.887
=1.99

Ananda Pharma's Ending Cash Position for the quarter that ended in Jul. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €0.00 Mil mean?
Ananda Pharma (STU:1FX) has a Ending Cash Position of €0.00 Mil as of Jul. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Ananda Pharma and its competitors.
Is Ananda Pharma's Ending Cash Position too high?
Ananda Pharma's current Ending Cash Position is €0.00 Mil.
How does Ananda Pharma's Ending Cash Position compare to ZTS and UTHR?
Ananda Pharma's Ending Cash Position of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Ananda Pharma and its competitors. Ananda Pharma's current Ending Cash Position is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ananda Pharma stock overvalued right now?
Ananda Pharma (STU:1FX) has a current Ending Cash Position of €0.00 Mil. The current Ending Cash Position is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Ananda Pharma (STU:1FX), the current Ending Cash Position is €0.00 Mil as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ananda Pharma Business Description

Address 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).